Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression

Abstract

BackgroundCurcumin is a polyphenol and the one of the principle curcuminoids of the spice turmeric. Its antioxidant, anti-cancer and anti-inflammatory effects have been intensively studied. Previous in vivo studies showed that administration of curcumin also decreased cholesterol levels in the blood, and the effects were considered to be related to upregulation of LDL receptor. However, since plasma cholesterol levels are also influenced by the uptake of cholesterol in the gut, which is mediated by a specific transporter Niemann-Pick Cl-like 1 (NPC1L1) protein, the present study is to investigate whether curcumin affects cholesterol uptake in the intestinal Caco-2 cells.MethodsCaco-2 cells were cultured to confluence. The micelles composed of bile salt, monoolein, and 14C-cholesterol were prepared. We first incubated the cells with the micelles in the presence and absence of ezetimibe, the specific inhibitor of NPC1L1, to see whether the uptake of the cholesterol in the cells was mediated by NPC1L1. We then pretreated the cells with curcumin at different concentrations for 24 h followed by examination of the changes of cholesterol uptake in these curcumin-treated cells. Finally we determined whether curcumin affects the expression of NPC1L1 by both Western blot analysis and qPCR quantification.ResultsWe found that the uptake of radioactive cholesterol in Caco-2 cells was inhibited by ezetimibe in a dose-dependent manner. The results indicate that the uptake of cholesterol in this study was mediated by NPC1L1. We then pretreated the cells with 25-100 μM curcumin for 24 h and found that such a treatment dose-dependently inhibited cholesterol uptake with 40% inhibition obtained by 100 μM curcumin. In addition, we found that the curcumin-induced inhibition of cholesterol uptake was associated with significant decrease in the levels of NPC1L1 protein and NPC1L1 mRNA, as analyzed by Western blot and qPCR, respectively.ConclusionCurcumin inhibits cholesterol uptake through suppression of NPC1L1 expression in the intestinal cells.

Lack of efficacy of curcumin on neurodegeneration in the mouse model of Niemann–Pick C1

“…Curcumin antagonizes the NFKappa pathway, exerting pro-apoptotic effects on cancer cells and anti-inflammatory activities through modulation of the redox status of the cell (reviewed by Sandur et al, 2007). Curcumin also inhibits the expression of NPC1L1, the ezetimide-inhibitable intestinal cholesterol uptake protein (Feng et al, 2010; Kumar et al, 2011), but this can not be the mechanism in mice as there is no cholesterol in their diet and they synthesize all of their own cholesterol.…”

The Role of Turmeric Powder in Lipid Metabolism and Its Effect on Quality of the First Quail’s Egg

“…Niemann-Pick protein C1-Like 1 (NPC1L1) is a protein that was identified as a specific transporter for the absorption of cholesterol in the plasma membrane surface. Curcumin can lower serum cholesterol levels by inhibiting absorption through NPC1L1 transporter (Feng et al, 2010). Decrease in the reabsorption of bile acids cause a feedback mechanism so that a large amount of blood cholesterol was converted into bile acids that could lower cholesterol levels in the serum.…”

Bisphenol A promotes cholesterol absorption in Caco-2 cells by up-regulation of NPC1L1 expression

“…Methods for cell free extract and Western blotting has been previously described [22, 24]. In brief, 40 μg of proteins in cell lysate was subjected to 7.5% SDS-PAGE and transferred to a nitrocellulose membrane electrophoretically overnight.…”